Published peer-reviewed research, clinical studies, and FDA regulatory data supporting the therapeutic benefits of the Biomat.
Research conducted specifically on the Richway Biomat and its far-infrared amethyst technology.
A peer-reviewed clinical study published in MedCrave Online Journal of Clinical Case Reports (Vol. 3, Issue 2, 2015; DOI: 10.15406/mojcr.2015.03.00055) tracked 12 cancer patients over 6 months. Stress levels dropped 52%, confirmed by EEG, ECG, and QRMA bio-resonance analysis. Cortisol decreased from 16.7 to 12.5 ng/mL (25% reduction). HRV improved from 3.25 to 5.25 (62% improvement).
12 cancer patients used the Biomat 3× per week for 6 months. 100% showed measurable improvement: pain reduced 21%, hsCRP (inflammation) decreased 15%, ICAP scores improved from 646 to 477, and QRMA bio-resonance improved from 64.5 to 46.8.
Clinical measurement showed a 25% reduction in cortisol levels (16.7 → 12.5 ng/mL) in subjects using far-infrared amethyst therapy. Lower cortisol supports the body's shift into parasympathetic mode — critical for deep sleep and tissue repair. HRV improved 62% (3.25 → 5.25), confirming autonomic recovery.
Dr. Nobuhiro Yoshimizu, M.D., Ph.D. (former Director, Yokohama General Hospital; Mayo Clinic) documented cases where lung metastases disappeared after 6 months and breast cancer tumors shrank from 3 cm to 1 cm using thermotherapy protocols. His research on 17 cancer patients establishes the hypothermia–immune connection: cancer patients often have low body temperatures, impairing immune function. Far-infrared therapy restores normal core temperatures to support natural immune surveillance.
Far-infrared rays emitted through the Biomat's amethyst crystal layer penetrate 6–8 cm into the body — reaching muscles, joints, organs, and connective tissue. This is dramatically deeper than surface-level heating pads (1–2 mm) or conventional infrared devices.
The Biomat holds FDA 510(k) clearance as a Class II medical device — a designation that requires demonstrating the device is safe and effective for its intended use. Very few infrared mat competitors hold this classification.
FDA-registered indications include:
Published studies from PubMed, NIH, and international medical journals supporting the therapeutic mechanisms behind the Biomat's technology.
Systematic review found far-infrared therapy is a promising complementary treatment for knee osteoarthritis, fibromyalgia, chronic low back pain, chronic myofascial syndrome, and sacroiliitis. Significant pain reduction observed across multiple studies.
Systematic review confirmed that far-infrared radiation produces thermal and non-thermal effects, including increasing artery blood flow, peripheral circulation, and endothelial function. Benefits observed in congestive heart failure, chronic pain, and wound healing.
Comprehensive review of far-infrared biological effects: improved microcirculation, modulation of biochemical molecules, enhanced wound healing, stimulation of cellular proliferation, and anti-inflammatory properties confirmed at the cellular level.
Review identifies FIR as a promising non-invasive therapy for regenerative medicine, noting benefits for tissue repair, reduction of oxidative stress, mitochondrial function improvement, and anti-inflammatory signaling pathways.
Four weeks of far-infrared radiation administered to type 2 diabetes patients significantly reduced cortisol levels and blood glucose. Demonstrates FIR's systemic stress-reduction and metabolic regulatory effects.
Randomized clinical trial demonstrated that far-infrared emission significantly improved local skin perfusion, microcirculation, and tissue oxygenation — confirming the vascular mechanism behind FIR therapy benefits.
Studies report that far-infrared emitting materials improve quality of sleep, likely through cortisol reduction, parasympathetic nervous system activation, and endorphin release. Improved slow-wave sleep observed in multiple cohorts.
Review demonstrates infrared therapy's potential in metabolic disease management through enhanced mitochondrial function, reduced inflammatory markers, improved insulin sensitivity, and modulation of adipose tissue metabolism.
Far-infrared heat activates Heat Shock Proteins (HSPs), a family of molecular chaperones that repair damaged proteins, protect cells from stress, and support immune function. HSP activation is a key mechanism behind the Biomat's deep therapeutic effects — the same pathway studied in longevity and recovery research worldwide.
The Biomat generates approximately 1,500 negative ions per cubic centimeter. Research shows negative ions improve mood, reduce stress, enhance sleep quality, and increase serotonin activity. Found naturally near waterfalls, forests, and ocean surf — the Biomat recreates this environment therapeutically.
The information on this page is provided for educational purposes. The Biomat is an FDA-cleared Class II medical device registered for the indications listed above. Individual results may vary. Far-infrared therapy research is ongoing and should not replace professional medical advice. Always consult your healthcare provider before beginning any new therapeutic regimen.
Browse our Biomat lineup and discover which model is right for your wellness goals.
Have questions? Browse FAQ · Read our blog